We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Outlines Generic Drugmaker Decisions for Setting Dissolution Specifications
EMA Outlines Generic Drugmaker Decisions for Setting Dissolution Specifications
The European Medicines Agency released a reflection paper to help guide generic drugmakers through the process of setting specifications for in vitro dissolution of immediate-release oral drugs.